Pacira BioSciences, Inc. — Director's Dealing 2021

Jun 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira BioSciences, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2021-06-04

Reporting Person: McLoughlin Dennis (Chief Customer Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-04	Common Stock	S	1895	$61.037	Disposed	27541	Direct

Footnotes

F1: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

F2: Includes 355 and 183 shares of common stock acquired under the issuer's employee stock purchase plan in June 2020 and December 2020, respectively.